,drug_name,drug_type,Smiles
0,Aldosterone,HLp2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
1,Alfentanil,HLp2-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
2,Alprazolam,HLp2-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
3,Amiodarone,HLp2-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
4,Amitriptyline,HLp2-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5,Amlodipine,HLp2-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
6,Amprenavir,HLp2-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
7,Aprepitant,HLp2-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
8,Argatroban,HLp2-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
9,Aripiprazole,HLp2-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
10,Astemizole,HLp2-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
11,Atazanavir,HLp2-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
12,Atazanavir,HLp2-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
13,Atorvastatin,HLp2-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
14,Aztreonam,HLp2-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
15,Beclometasone,HLp2-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
16,Buspirone,HLp2-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
17,Caffeine,HLp2-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
18,Carbamazepine,HLp2-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
19,Carbamazepine,HLp2-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
20,Cerivastatin,HLp2-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
21,Chinin,HLp2-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
22,Chloroquine,HLp2-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
23,Chlorphenamine,HLp2-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
24,Chlorpromazine,HLp2-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
25,Ciclosporin,HLp2-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
26,Ciclosporin,HLp2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
27,Ciclosporin,HLp2-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
28,Cimetidine,HLp2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
29,Cisapride,HLp2-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
30,Clarithromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
31,Clopidogrel,HLp2-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
32,Cocaine,HLp2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
33,Cocaine,HLp2-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
34,Codeine,HLp2-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
35,Cortisone,HLp2-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
36,Cyclobarbital,HLp2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
37,Dapsone,HLp2-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
38,Daunorubicin,HLp2-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
39,Dexamethasone,HLp2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
40,Dexamethasone,HLp2-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
41,Dextromethorphan,HLp2-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
42,Diazepam,HLp2-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
43,Diethyltoluamide,HLp2-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
44,Diltiazem,HLp2-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
45,Diltiazem,HLp2-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
46,Disulfiram,HLp2-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
47,Docetaxel,HLp2-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
48,Domperidone,HLp2-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
49,Doxorubicin,HLp2-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
50,Doxylamin,HLp2-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
51,Dutasteride,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
52,Eplerenone,HLp2-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
53,Erythromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
54,Erythromycin,HLp2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
55,Estradiol,HLp2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
56,Estrone,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
57,Ethinylestradiol,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
58,Ethosuximide,HLp2-Substrate,CC[C@]1(C)CC(=O)NC1=O
59,Etoposide,HLp2-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
60,Etoposide,HLp2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
61,Felodipine,HLp2-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
62,Fentanyl,HLp2-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
63,Finasteride,HLp2-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
64,Fluconazole,HLp2-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
65,Fluconazole,HLp2-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
66,Flutamide,HLp2-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
67,Fluvoxamine,HLp2-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
68,Glycyrrhizic Acid,HLp2-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
69,Glycyrrhizic Acid,HLp2-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
70,Granisetron,HLp2-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
71,Halofantrine,HLp2-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
72,Haloperidol,HLp2-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
73,Hydrocortisone,HLp2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
74,Ifosfamide,HLp2-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
75,Imatinib,HLp2-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
76,Imatinib,HLp2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
77,Indinavir,HLp2-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
78,Indinavir,HLp2-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
79,Irinotecan,HLp2-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
80,Ketoconazole,HLp2-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
81,Ketoconazole,HLp2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
82,Ketoconazole,HLp2-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
83,Lercanidipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
84,Levacetylmethadol,HLp2-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
85,Lidocain,HLp2-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
86,Linopirdine,HLp2-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
87,Losartan,HLp2-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
88,Lovastatin,HLp2-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
89,Mepacrine,HLp2-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
90,Mephenytoin,HLp2-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
91,Methadone,HLp2-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
92,Mibefradil,HLp2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
93,Midazolam,HLp2-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
94,Mifepristone,HLp2-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
95,Mifepristone,HLp2-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
96,Modafinil,HLp2-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
97,Modafinil,HLp2-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
98,Nateglinide,HLp2-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
99,Nefazodone,HLp2-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
100,Nelfinavir,HLp2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
101,Nelfinavir,HLp2-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
102,Neostigmine,HLp2-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
103,Nicardipine,HLp2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
104,Nifedipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
105,Nimodipine,HLp2-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
106,Nisoldipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
107,Nitrendipine,HLp2-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
108,Norethisterone,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
109,Norfloxacin,HLp2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
110,Octopamine,HLp2-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
111,Omeprazole,HLp2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
112,Omeprazole,HLp2-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
113,Omeprazole,HLp2-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
114,Ondansetron,HLp2-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
115,Ornidazole,HLp2-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
116,Oxazepam,HLp2-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
117,Oxcarbazepine,HLp2-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
118,Oxybutynin,HLp2-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
119,Oxycodone,HLp2-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
120,Paclitaxel,HLp2-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
121,Paracetamol,HLp2-Inducer,CC(=O)NC1=CC=C(O)C=C1
122,Paracetamol,HLp2-Substrate,CC(=O)NC1=CC=C(O)C=C1
123,Paraoxon,HLp2-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
124,Pethidine,HLp2-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
125,Phenelzine,HLp2-Inhibitor,NNCCC1=CC=CC=C1
126,Phenelzine,HLp2-Substrate,NNCCC1=CC=CC=C1
127,Phenobarbital,HLp2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
128,Phenytoin,HLp2-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
129,Physostigmine,HLp2-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
130,Pimozide,HLp2-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
131,Pleconaril,HLp2-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
132,Pravastatin,HLp2-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
133,Praziquantel,HLp2-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
134,Prednisolone,HLp2-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
135,Prednisolone,HLp2-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
136,Progesterone,HLp2-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
137,Propranolol,HLp2-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
138,Quetiapine,HLp2-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
139,Ranitidine,HLp2-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
140,Reserpine,HLp2-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
141,Rifampicin,HLp2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
142,Rifampicin,HLp2-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
143,Rifampicin,HLp2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
144,Rifapentine,HLp2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
145,Risperidone,HLp2-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
146,Ritonavir,HLp2-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
147,Ritonavir,HLp2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
148,Ritonavir,HLp2-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
149,Rosuvastatin,HLp2-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
150,Salmeterol,HLp2-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
151,Saquinavir,HLp2-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
152,Saquinavir,HLp2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
153,Sildenafil,HLp2-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
154,Simvastatin,HLp2-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
155,Sirolimus,HLp2-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
156,Spironolactone,HLp2-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
157,Sulfasalazine,HLp2-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
158,Tacrolimus,HLp2-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
159,Tamoxifen,HLp2-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
160,Tegafur,HLp2-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
161,Telithromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
162,Teniposide,HLp2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
163,Terfenadine,HLp2-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
164,Testosterone,HLp2-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
165,Thalidomide,HLp2-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
166,Tocopherol (vit E),HLp2-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
167,Trazodone,HLp2-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
168,Triamcinolone,HLp2-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
169,Triazolam,HLp2-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
170,Troglitazone,HLp2-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
171,Troglitazone,HLp2-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
172,Vardenafil,HLp2-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
173,Verapamil,HLp2-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
174,Verapamil,HLp2-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
175,Vinblastine,HLp2-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
176,Vincristine,HLp2-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
177,Zalcitabine,HLp2-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
178,Zaleplon,HLp2-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
179,Ziprasidone,HLp2-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
180,Zolpidem,HLp2-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
181,Zonisamide,HLp2-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
182,Zotepine,HLp2-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
